Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Alefacept + MTX in Psoriatic Arthritis
NCT00659412Phase 2Completed
- Sponsor
- Astellas Pharma
- Start
- Sep 2003
- Primary completion
- Mar 2005
- Modality
- Fc-Fusion Proteins
- Countries
- 5
01
Overview
A Phase 2 trial of alefacept in psoriatic arthritis (PsA), sponsored by Astellas Pharma. Started Sep 2003; status: completed.
02
Drugs
alefacept
03
Conditions
psoriatic arthritis (PsA)
Beyond the preview
Go deeper on NCT00659412.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00659412.